Global Gene Expression Analysis Market to Reach $6.6 Billion by 2027 at a 9.2% CAGR - ResearchAndMarkets.com

The "Gene Expression Analysis: Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Global Gene Expression Analysis Market to Reach $6.6 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Gene Expression Analysis estimated at US$3.6 Billion in the year 2020, is projected to reach a revised size of US$6.6 Billion by 2027, growing at a CAGR of 9.2% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 8.7% CAGR and reach US$2.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Consumables segment is readjusted to a revised 9.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $974.5 Million, While China is Forecast to Grow at 13.7% CAGR

The Gene Expression Analysis market in the U.S. is estimated at US$974.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2027 trailing a CAGR of 13.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 8.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$914.9 Million by the year 2027.

Services Segment to Record 9% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$538.5 Million in the year 2020 will reach a projected size of US$942.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 10.5% CAGR through the analysis period.

Select Competitors (Total 42 Featured) -

• Agilent Technologies
• Bgi
• Bio-Rad Laboratories, Inc.
• ELITechGroup
• Eurofins Scientific
• F. Hoffmann-La Roche
• Ge Healthcare
• Illumina,Inc.
• Novogene Corporation
• Oxford Gene Technology
• Pacific Biosciences of California, Inc.
• Perkinelmer, Inc.
• Qiagen N.V.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession
• Gene Expression Analysis - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Companies Mentioned

• Agilent Technologies
• Bgi
• Bio-Rad Laboratories, Inc.
• ELITechGroup
• Eurofins Scientific
• F. Hoffmann-La Roche
• Ge Healthcare
• Illumina,Inc.
• Novogene Corporation
• Oxford Gene Technology
• Pacific Biosciences of California, Inc.
• Perkinelmer, Inc.
• Qiagen N.V.
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/oxr2xv.